Algernon Health Inc.
AGN
CNSX
| 08/31/2025 | 05/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -34.42% | 57.58% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -35.32% | 60.97% | |||
| Operating Income | 35.32% | -60.97% | |||
| Income Before Tax | 33.12% | -59.48% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 33.12% | -59.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.12% | -59.48% | |||
| EBIT | 35.32% | -60.97% | |||
| EBITDA | 40.86% | -61.20% | |||
| EPS Basic | 43.36% | -50.53% | |||
| Normalized Basic EPS | 42.70% | -48.33% | |||
| EPS Diluted | 43.36% | -50.53% | |||
| Normalized Diluted EPS | 42.70% | -48.33% | |||
| Average Basic Shares Outstanding | 18.08% | 6.37% | |||
| Average Diluted Shares Outstanding | 18.08% | 6.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||